KorrekturOpen Access · CC BY 4.0
Correction to “Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real‐World Effectiveness and Safety From a Prospective Cohort”
ACR Open Rheumatology · 2026-10 · 8 (10)
DOI: 10.1002/acr2.90165 ↗Kurz gefasst
Korrektur in der Zeitschrift ACR Open Rheumatology, online erschienen am 01.10.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real‐World Effectiveness and Safety From a Prospective Cohort”. ACR Open Rheumatology, 8(10). https://doi.org/10.1002/acr2.90165
Vancouver
Correction to “Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real‐World Effectiveness and Safety From a Prospective Cohort”. ACR Open Rheumatology. 2026;8(10). doi:10.1002/acr2.90165
BibTeX
@article{euvimed2026,
title = {Correction to “Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real‐World Effectiveness and Safety From a Prospective Cohort”},
journal = {ACR Open Rheumatology},
year = {2026},
volume = {8},
number = {10},
doi = {10.1002/acr2.90165}
}
EUVIMED